PubRank

S E Vollset

Author PubWeight™ 105.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997 5.35
2 Homocysteine and cardiovascular disease. Annu Rev Med 1998 4.69
3 The Norwegian Arthroplasty Register: 11 years and 73,000 arthroplasties. Acta Orthop Scand 2000 3.66
4 Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr 2001 3.04
5 Hip disease and the prognosis of total hip replacements. A review of 53,698 primary total hip replacements reported to the Norwegian Arthroplasty Register 1987-99. J Bone Joint Surg Br 2001 2.66
6 The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000 2.45
7 Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr 1998 2.41
8 Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995 2.31
9 The effect of the type of cement on early revision of Charnley total hip prostheses. A review of eight thousand five hundred and seventy-nine primary arthroplasties from the Norwegian Arthroplasty Register. J Bone Joint Surg Am 1995 2.21
10 Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001 2.13
11 Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet 2003 2.03
12 Medium- and long-term performance of 11,516 uncemented primary femoral stems from the Norwegian arthroplasty register. J Bone Joint Surg Br 2007 1.97
13 The type of cement and failure of total hip replacements. J Bone Joint Surg Br 2002 1.92
14 Patient satisfaction and function after primary and revision total hip replacement. Clin Orthop Relat Res 1998 1.65
15 Mortality after total hip replacement: 0-10-year follow-up of 39,543 patients in the Norwegian Arthroplasty Register. Acta Orthop Scand 2000 1.64
16 Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. Am J Clin Nutr 1997 1.58
17 Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg Br 1997 1.49
18 Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study. QJM 2006 1.46
19 Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. A nested case-control study. Scand J Gastroenterol 1999 1.45
20 [Folate and health--new knowledge and new recommendation]. Tidsskr Nor Laegeforen 1998 1.38
21 Failure mechanisms after unicompartmental and tricompartmental primary knee replacement with cement. J Bone Joint Surg Am 2007 1.34
22 Patient-related risk factors for early revision of total hip replacements. A population register-based case-control study of 674 revised hips. Acta Orthop Scand 1997 1.33
23 Failure rates for 4762 revision total hip arthroplasties in the Norwegian Arthroplasty Register. J Bone Joint Surg Br 2004 1.31
24 Total homocysteine and cardiovascular disease. J Intern Med 1999 1.23
25 Exeter and charnley arthroplasties with Boneloc or high viscosity cement. Comparison of 1,127 arthroplasties followed for 5 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 1997 1.21
26 Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action Project. Circulation 2001 1.20
27 Revision for aseptic loosening of uncemented cups in 4,352 primary total hip prostheses. A report from the Norwegian Arthroplasty Register. Acta Orthop Scand 1995 1.19
28 The economic impact of failures in total hip replacement surgery: 28,997 cases from the Norwegian Arthroplasty Register, 1987-1993. Acta Orthop Scand 1996 1.16
29 Early aseptic loosening of uncemented femoral components in primary total hip replacement. A review based on the Norwegian Arthroplasty Register. J Bone Joint Surg Br 1995 1.16
30 Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism. Clin Chem 2000 1.13
31 Early revision among 12,179 hip prostheses. A comparison of 10 different brands reported to the Norwegian Arthroplasty Register, 1987-1993. Acta Orthop Scand 1995 1.10
32 Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study. J Clin Invest 1996 1.09
33 Milk consumption and cancer incidence: a Norwegian prospective study. Br J Cancer 1990 1.08
34 A community-based study on determinants of circulating markers of cellular immune activation and kynurenines: the Hordaland Health Study. Clin Exp Immunol 2013 1.03
35 High intake of energy, sucrose, and polyunsaturated fatty acids is associated with increased risk of preeclampsia. Am J Obstet Gynecol 2001 1.02
36 Determinants of cobalamin status in newborns. Pediatrics 2001 1.01
37 Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum. Am J Med Genet 2001 1.00
38 Malformation surveillance and maternal drug exposure: the MADRE project. Int J Risk Saf Med 1994 0.99
39 The effect of hospital-type and operating volume on the survival of hip replacements. A review of 39,505 primary total hip replacements reported to the Norwegian Arthroplasty Register, 1988-1996. Acta Orthop Scand 1999 0.99
40 Impact of multiple births and elective deliveries on the trends in low birth weight in Norway, 1967-1995. Am J Epidemiol 1999 0.99
41 Early failures among 14,009 cemented and 1,326 uncemented prostheses for primary coxarthrosis. The Norwegian Arthroplasty Register, 1987-1992. Acta Orthop Scand 1994 0.98
42 Risk factors for embolisation in patients with left ventricular thrombi and acute myocardial infarction. Br Heart J 1988 0.97
43 Prognostic factors and survival in amyotrophic lateral sclerosis. Neuroepidemiology 1994 0.97
44 The Hordaland Homocysteine Studies. Lipids 2001 0.95
45 Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study. Am J Clin Nutr 1999 0.94
46 Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials. J Intern Med 2010 0.94
47 Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology 2000 0.92
48 Serum opsonins to serogroup B meningococci in meningococcal disease. Scand J Infect Dis 1989 0.92
49 Apolipoprotein E epsilon4 and impaired episodic memory in community-dwelling elderly people: a marked sex difference. The Hordaland Health Study. J Neurol Neurosurg Psychiatry 2006 0.91
50 Smoking and ulcer perforation. Gut 1997 0.91
51 Perinatal and infant mortality in term and preterm births among women with type 1 diabetes. Diabetologia 2011 0.91
52 Evaluation of diagnostic tests for antinuclear antibodies in rheumatological practice. Scand J Immunol 2000 0.90
53 Methylmalonic acid and homocysteine in plasma as indicators of functional cobalamin deficiency in infants on macrobiotic diets. Pediatr Res 1994 0.89
54 Trends in 28-day and 1-year mortality rates in patients hospitalized for a first acute myocardial infarction in Norway during 2001-2009: a "Cardiovascular disease in Norway" (CVDNOR) project. J Intern Med 2014 0.87
55 Do reproductive factors influence colorectal cancer survival? J Clin Epidemiol 1995 0.87
56 Intracellular localization of palmitoyl-CoA hydrolase and palmitoyl-CoA synthetase in human blood platelets and liver. Scand J Clin Lab Invest 1980 0.87
57 Distribution and determinants of serum creatinine in the general population: the Hordaland Health Study. Scand J Clin Lab Invest 2004 0.87
58 The Norwegian arthroplasty register. A survey of 17,444 hip replacements 1987-1990. Acta Orthop Scand 1993 0.86
59 Risk factors for bacteriuria and clinical urinary tract infection in patients treated with clean intermittent catheterization. J Urol 1993 0.85
60 The Hordaland homocysteine study: the opposite tails odds ratios reveal differential effects of gender and intake of vitamin supplements at high and low plasma total homocysteine concentrations. J Nutr 1996 0.83
61 A study of assay conditions for palmitoyl-CoA synthetase and carnitine palmitoyltransferase in homogenates of human blood platelets. Scand J Clin Lab Invest 1979 0.83
62 Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. J Intern Med 2007 0.83
63 Epidemiology of amyotrophic lateral sclerosis in Hordaland county, western Norway. Acta Neurol Scand 1991 0.83
64 Survival of the Charnley hip in coxarthrosis. A 10-15-year follow-up of 629 cases. Acta Orthop Scand 1991 0.83
65 Population density and perinatal mortality in Norway and Sweden 1975-1988. Scand J Public Health 1999 0.83
66 Reproductive factors and survival from ovarian cancer. Int J Cancer 1993 0.83
67 Maternal exposure to lorazepam and anal atresia in newborns: results from a hypothesis-generating study of benzodiazepines and malformations. J Clin Psychopharmacol 2001 0.82
68 Infant mortality in Norway and Sweden 1975-88: a cause-specific analysis of an increasing difference. Paediatr Perinat Epidemiol 1997 0.82
69 Elevated plasma total homocysteine and C677T mutation of the methylenetetrahydrofolate reductase gene in patients with spina bifida. QJM 1997 0.81
70 A 3-month double-blind cross-over study of the effect of benazepril and hydrochlorothiazide on functional class in symptomatic mild heart failure. J Intern Med 1992 0.81
71 Does consumption of fruit and vegetables protect against stroke? Lancet 1983 0.81
72 Serum opsonins to serogroup B meningococci after disease and vaccination. NIPH Ann 1991 0.81
73 Cerebrospinal fluid proteins as indicators of nerve root compression in patients with sciatica caused by disc herniation. Spine (Phila Pa 1976) 1993 0.80
74 Plasma total homocysteine is influenced by prandial status in humans: the Hordaland Hhomocysteine Sstudy. J Nutr 2001 0.80
75 Plasma sulfur amino acids and stearoyl-CoA desaturase activity in two Caucasian populations. Prostaglandins Leukot Essent Fatty Acids 2013 0.79
76 Infant survival in Norway and Sweden 1985-88. Acta Paediatr 1994 0.78
77 Endogenous serotonin in human blood platelets: factors that may influence reference values. Platelets 1996 0.78
78 Cod liver oil consumption, smoking, and coronary heart disease mortality: three counties, Norway. Int J Circumpolar Health 2001 0.77
79 [Artificial hip joints in Norway. A national registry of total hip arthroplasties]. Tidsskr Nor Laegeforen 1992 0.77
80 Immunization against serogroup B meningococci. Opsonin response in vaccinees as measured by chemiluminescence. APMIS 1991 0.77
81 Population determinants of homocysteine. Am J Clin Nutr 2001 0.77
82 Cerebrospinal fluid protein concentrations in patients with sciatica caused by lumbar disc herniation: an investigation of biochemical, neurologic, and radiologic predictors of long-term outcome. J Spinal Disord 1997 0.75
83 Coffee and homocysteine. Am J Clin Nutr 2000 0.75
84 Confounding of algorithmic efficiency by programming language in exact odds ratio estimation. Epidemiology 1992 0.75
85 Ovulation induction and neural tube defects. Lancet 1990 0.75
86 Antimicrobial therapy and case fatality in meningococcal disease. Scand J Infect Dis 1987 0.75
87 Survival of total hip arthroplasties after DDH in the Norwegian Arthroplasty Register 1987-2004. Hip Int 2007 0.75
88 Efficient power computation for exact and mid-P tests for the common odds ratio in several 2 x 2 tables. Stat Med 1994 0.75
89 Sensitivities of lupus anticoagulant assays. Am J Hematol 1989 0.75
90 Association of hepatitis B and human immunodeficiency virus infections in Tanzanian population groups. Eur J Clin Microbiol Infect Dis 1993 0.75
91 Exact power computation for dose-response studies. Stat Med 1995 0.75
92 [How many persons do we need for clinical trials? Analysis of the 2 x 2 table]. Tidsskr Nor Laegeforen 1983 0.75
93 Reduction of exercise-induced ventricular arrhythmias in mild symptomatic heart failure by benazepril. Am Heart J 1993 0.75
94 Plasma dimethylglycine, nicotine exposure and risk of low bone mineral density and hip fracture: the Hordaland Health Study. Osteoporos Int 2015 0.75
95 Homocysteine and its relation to B-vitamins in Graves' disease before and after treatment: effect modification by smoking. J Intern Med 2003 0.75
96 [The hip registry. Good economy for society]. Tidsskr Nor Laegeforen 1996 0.75
97 Physical complications in patients treated with clean intermittent catheterization. Scand J Urol Nephrol 1993 0.75
98 Cerebrospinal fluid protein concentrations related to clinical findings in patients with sciatica caused by disk herniation. J Spinal Disord 1994 0.75
99 Statistical methods for surveillance of congenital malformations: when do the data indicate a true shift in the risk that an infant is affected by some type of malformation? Int J Risk Saf Med 1991 0.75
100 Association between Weight Change and Mortality in Community Living Older People Followed for Up to 14 Years. The Hordaland Health Study (HUSK). J Nutr Health Aging 2017 0.75
101 [Risk factors of deliveries during transport in Norway 1967-88]. Tidsskr Nor Laegeforen 1991 0.75